Dr. Craig Smith is an Executive Vice President of Algenol.
Craig’s background includes co-founding and serving as Chairman, President and Chief Executive Officer of Guilford Pharmaceuticals, Inc., a publicly held biopharmaceutical company, from 1993 to 2004. Dr. Smith served in various senior roles from 1988 to 1992 at Centocor, Inc., a publicly held biotechnology company, which is now a wholly owned subsidiary of Johnson & Johnson.From 1975 to 1988, Dr. Smith served on the faculty of the Department of Medicine at The Johns Hopkins University School of Medicine.
Dr. Smith has served on many corporate and charitable boards including the Johns Hopkins Alliance for Science, the Board of Directors of Adams Express Company (NYSE: ADX), a publicly held closed-end equity investment company, Petroleum & Resources Corporation (NYSE: PEO), a publicly held equity investment company specializing in energy and natural resources, and Depomed, Inc. (NASDAQ: DEPO), a publicly held specialty pharmaceutical company. Dr. Smith has received numerous awards and honors, including the 1997 Maryland Entrepreneur of the Year Award and election to the Johns Hopkins Society of Scholars in 2000. He received his B.A. from the University of the South in Sewanee, Tennessee, and his M.D. from State University of New York at Buffalo.
International Economic Forum
of the Americas
2075 Robert-Bourassa Blvd.
H3A 2L1 Canada
Telephone: 514 871-2225
Toll-free phone: 1 866 865-2225
Fax: 514 871-2226